Aclaris Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LMT
8. USO
9. TLT
10. AMZN

Go back to Aclaris Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
(NASDAQ: ACRS) Delayed: 5.40 +0.08 (1.50%)
Previous Close $5.32    52 Week High $33.88 
Open $5.37    52 Week Low $14.12 
Day High $5.63    P/E N/A 
Day Low $5.34    EPS $0.00 
Volume 3,822,970